Includes Initial Purchase Order for 500 Needle-Free Devices and Minimum Commitment of 13,500 Devices
TORONTO, ON / ACCESSWIRE / July 5, 2022 /NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce a five-year exclusive sales and distribution agreement (the "Agreement") with SOL-MILLENNIUM Medical Group ("Sol-Millennium" or "Sol-M"), a global healthcare company dedicated to the design, manufacturing, and distribution of high-quality medical devices and personal protective equipment for patients and clinicians around the world.
Sol-M is a global entity with offices throughout the world and operates two state-of-the-art manufacturing and R&D Centers in Lugano, Switzerland and Shanghai, China and has a global presence with additional offices in Sao Paulo, Brazil, Warsaw,Poland and Atlanta, Georgia, USA. Originally a leading producer of plastic molds for the global medical industry, Sol-Millennium was the first syringe mold producer in China and now supplies over 60% of China's syringe mold needs, as well as exporting globally.
NuGen M.D.'s needle-free injection system, also known as InsuJet™, is a self-administered needle-free injection system approved by Health Canada and Brazil for general use and specifically for the delivery of Insulin. It gives access to safe, cost-effective, and virtually pain-free drug delivery for the millions of patients who suffer from diabetes or other chronic illnesses. The InsuJet™ also holds a CE Mark and is approved for sale in over 40 countries around the globe.
Starting July 01st, 2002, NuGen M.D is granting Sol-Millennium exclusive rights to promote, sell, and distribute the NuGen needle-free injection device known as InsuJet™ for the injection of insulin treatments in humans in Canada and Brazil. In return, the distributor undertakes to exclusively represent the NuGen product line of needle-free devices for use in humans in Canada and Brazil.
The first 2.5 years of the 5-year agreement has minimum commitments of 750 devices plus components in 2022, 5,000 devices plus components in 2023, and 8,000 devices plus components in 2024 for a total of 13,750 devices plus components. Year four and five minimum quantities will be determined at a later date as additional countries and application segments may be added to the agreement. The execution of this agreement triggers a minimum purchase order of 500 devices plus components.
"This is an important moment for NuGen and its shareholders as this agreement is with one of the leading manufacturers and distributors of traditional hypodermic needles and safety syringes with global distribution and sales. Based on our internal analysis, each device sold represents ~$650CDN* in revenue including the recurring components over the ~3 year lifetime of a device." states Michael Wright, CEO of NuGen M.D. "The InsuJet™ provides 5,000 injections of insulin, which reduces long term costs of injections, generates less biohazard waste, eliminates needlestick injury all while delivering the medication without anxiety. This not only reduces financial strain on the patient but removes an enormous financial burden on the healthcare system and environment."
According to the International Diabetes Federation, 537 million people have diabetes in the world today, and Brazil accounts for 15.7 million diagnosed diabetics and another 5 million undiagnosed. Diabetes Canada 2022 statistics report over 4 million people or 10% of the population suffer from diabetes which increases to over 7 million or 17% of the population when including undiagnosed cases.
*Based on 5,000 injections per device, dependent on the patient using 3ml or 10ml vials, the dosage of insulin and the frequency of injections per day.
NuGen Medical Devices' principal business is the development and commercialization of innovative needle-free injection devices and systems for the administration of subcutaneous medication. It is developing needle-free drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis as well as DNA and conventional/pediatric vaccines.
For More Information visit: www.nugenmd.com Twitter: @NuGenMD LinkedIn: https://www.linkedin.com/company/nugenmd/
For further information, please contact:
Michael Wright President and CEO NuGen Medical Devices Inc. mw@nugenmd.com
Investor Relations Contact: Kin Communications Inc. NGMD@kincommunications.com (604) 684-6730
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this press release include the Company's 2022 objectives of securing additional distribution and sales agreements, making submissions for regulatory approvals and capitalizing on additional market opportunities. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.
View source version on accesswire.com: https://www.accesswire.com/707491/NuGen-MD-Signs-Exclusive-Sales-and-Distribution-Deal-with-Leading-Global-Healthcare-Company-Sol-Millenium-for-Canadian-and-Brazilian-Diabetes-Market
China International Capital Corp Ltd (CICC) has appointed veteran dealmaker Wang Shuguang to lead its investment banking business, said two people with knowledge of the matter. The appointment, effective July 11, comes as Wang Sheng, the bank's previous investment banking head, has moved to China Galaxy Securities to take over as chief executive of the smaller peer. CICC did not immediately respond to a request for comment.
The marquee hire will serve as president of the Kestra business that specializes in acquisitions of registered investment advisor firms.
Despite the Consumer Price Index (CPI) rate surging 9.1% in June, White House officials expect sticker prices, including gas prices, to decline as the administration continues to combat inflation.
The United branch of the Air Line Pilots Association (ALPA) said the current agreement "fell short" of some pilots' expectations, according to the report. United Airlines and ALPA did not immediately respond to a Reuters' request for comment. The two-year agreement, previously approved by union leaders, was sent out to members for ratification and expected to settle by July 15.
The fallout continues from the crypto industry's slump, with fresh filings from Celsius, layoffs at OpenSea and a short-squeeze in Voyager's tokens. PLUS: We talked to a Singapore-based lawyer about the Gordian knot that is the Three Arrows bankruptcy case.
(Bloomberg) -- Bailing out German energy giant Uniper SE is shaping up to be even more painful than the weeks-long, tangled and nearly-failed rescue of carrier Deutsche Lufthansa AG.Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesWall Street Texting Habit Sticks Banks With Rare $1 Billion BillBiden to Leave Mideast With No Immediate Announcement on OilEvery corner of the negotiation is difficult, with a dea
The value of deals struck in the first half of 2022 dropped to $144.2 billion, due to an ongoing stock market rout driven by fears of a looming recession, raging inflation and aggressive rate hikes, from $158.2 billion over the same period last year. The pace of VC activity is also expected to slow in the second half of 2022 as the threshold for closing deals rises and pricing uncertainty extends to the early stages of the investment cycle. "Exits remain extremely low while late-stage companies act with caution as a result of bearish public market activity," said John Gabbert, founder and chief executive of PitchBook.
Things are not improving for embattled crypto lending platform Celsius as a bankruptcy filing has caused its token price to plunge even further.
The U.S. was Richemont's largest single market in the April to June period, with sales climbing 41 percent to 1.34 billion euros due to domestic spending.
RBC Capital analyst Ken Herbert lowered the price target on Boeing Co (NYSE: BA) to $200 (39% upside) from $220 while maintaining the Outperform rating on the shares. The analyst states that the strong June deliveries support confidence into 2H22; the focus remains on the MAX production and delivery outlook, the 787 resumptions of deliveries, and the 2022 FCF guide. Herbert mentions that expectations around the Farnborough airshow are low, which could provide a positive catalyst. Also Read: Airb
(Bloomberg) -- Japanese Finance Minister Shunichi Suzuki voiced his concern over the yen’s sudden drop on the back of some speculative moves, speaking on the sidelines of a Group of 20 meeting in Indonesia. Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesWall Street Texting Habit Sticks Banks With Rare $1 Billion BillChina Growth Slows Sharply, Putting GDP Target Out of Reach“The yen has been extending loss
The Treasury yield curve is signaling to investors that recession risks have risen considerably in recent week.
Morgan Stanley autos analyst Adam Jonas is getting ahead of earnings season and looming economic slowdown, coming out with some cuts to profit forecasts and price targets.
Celsius Network, the crypto lender facing a liquidity crisis, has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Southern District of New York. Ropes & Gray LLP Partner Ryan Preston Dahl discusses the developments and potential ramifications for users.
Philippine central bank Governor Felipe Medalla discusses monetary policy, the economy and the local currency. Bangko Sentral ng Pilipinas unexpectedly raised borrowing costs by 75 basis points to 3.25% on Thursday. The Philippine peso is down more than 9% this year and adds to inflation in a country that imports goods from fuel to rice. Medalla speaks with David Ingles on "Bloomberg Markets: China Open."
The social media firm’s lawsuit to enforce its deal with Elon Musk is expected to begin soon in Delaware’s Chancery Court.
Jennifer Rumsey will take on the CEO role in August as the company pursues cleaner alternatives to diesel engines.
(Bloomberg) -- The worst rout in more than a decade for the US tech-focused Nasdaq 100 Stock Index has turned into a buying opportunity for Indian retail investors, who boosted holdings of Tesla Inc., Amazon.com Inc and Apple Inc. Most Read from BloombergChinese Homebuyers Across 22 Cities Refuse to Pay MortgagesUS Inflation Quickens to 9.1%, Amping Up Fed Pressure to Go BigFed Could Weigh Historic 100 Basis-Point Hike After Inflation ScorcherThe 10 Worst Airports in Europe for Delays Right NowM
Celsius Network's mining unit, which said in March it planned to go public, filed for chapter 11 bankruptcy protection along with its parent company. CoinDesk Managing Editor for Companies Aoyon Ashraf discusses the developing story and potential impact on the mining industry at large.
The U.S. dollar rose to its highest level versus the Japanese yen this century as traders bought the rampant buck in anticipation of more sharp rate rises from the Federal Reserve. The greenback rose 1.3% to 139.20 yen (USDJPY) the cheapest price for the Japanese currency since 1998. The yen has fallen by 21% against the dollar so far this year, a sharper move than the 12% drop for the euro and the 13% decline for the British pound.